In short. A vascular occlusion means an injectable filler has entered an artery, or a vessel connected to it, and been carried away from the injection point by the blood flow. The tissue at risk is downstream, not the treated area, and it fails progressively, so the interval from the first sign to treatment matters more than anything done later.
Key points
- Material enters a vessel at the needle tip and travels with the flow.
- The area at risk is downstream, so the injected site can look normal.
- Facial arteries connect, and some reach the blood supply of the eye.
- Skin without blood blisters, darkens, and may be lost.
- Severe pain, colour change or any visual change means emergency care now.
The journey the product takes
Arteries in the face follow patterns that are broadly predictable but not identical between people, and many communicate with one another. When the tip of a needle or a cannula enters the lumen of a vessel, the pressure of injection can drive material backwards along the artery, against the direction of normal flow. It is then swept forward into whatever territory that vessel supplies.
A small volume can therefore reach skin that was never treated and, in the vessels that connect to the blood supply of the eye, it can reach the retina.
Why is the damage not where the injection was?
This is the fact that makes an occlusion counter-intuitive. A patient whose cheek was injected may develop a pale, mottled patch on the side of the nose. An injection at the glabella can threaten the skin of the forehead. The treated area can look entirely normal while the tissue that matters is already short of blood.
The consequence is not a lump where the needle went in. It is tissue somewhere downstream that has stopped receiving blood, and it is that tissue, not the injected area, that is at risk. This single fact explains almost everything about how an occlusion presents and why it is treated as an emergency.
What happens to tissue without blood
Skin that loses its arterial supply does not simply look pale and then recover. The cells begin to fail within a short time, the surface blisters and later darkens, and affected tissue may be lost. The process is progressive while the obstruction persists, which is why the interval between the first sign and the start of treatment matters more than anything done afterwards.
Why some injections carry more risk
Certain areas are recognised as higher risk because of the vessels that pass through them: the glabella, the nose, the forehead, the temple and the tear trough. Previous surgery in the area, a sharp needle rather than a blunt cannula, and a larger volume delivered quickly all shift the odds. None of these makes an occlusion likely, and it can occur without any of them. They explain why an injector may choose a different approach, or decline the area altogether.
Which findings mean emergency care now?
The findings that matter fall into three groups: pain, colour, and anything involving the eye.
| Finding | What it means | What to do |
|---|---|---|
| A pale patch appears away from the treated area | Material has travelled along a connected vessel | Emergency care now |
| Skin turns white, grey, mottled or dusky | Tissue downstream of the needle is short of blood | Emergency care now |
| A lacy pattern appears, or the skin feels cold | The surface circulation is compromised | Emergency care now |
| Pain is severe out of proportion, or keeps worsening | A vessel is involved, not an ordinary injection ache | Emergency care now; do not wait for it to settle |
| There is any change in vision | Vessels feeding the eye may be obstructed | Emergency care now |
| A drooping eyelid, or pain and swelling around the eye | The eye and its surrounding tissue are affected | Emergency care now |
| Blistering is followed by darkening | Tissue has already failed | Attend now; this is not a sign to watch at home |
Any one of these findings is a reason to attend now rather than to wait.
What this changes about the decision
What follows is not an argument against filler. It is an argument for knowing the findings that mean something has gone wrong, and for treating them as a reason to attend rather than a reason to wait.
Sources
- NICE — guidance on cosmetic procedures and injectable fillers
- British Association of Plastic, Reconstructive and Aesthetic Surgeons — information on filler complications
- Royal College of Ophthalmologists — ocular complications of facial injectables
Internal links
Frequently asked questions
How does filler get into a blood vessel?
The tip of a needle or a cannula enters the lumen of an artery, and the pressure of the injection drives material into it. Many facial arteries are connected to one another, so the product is then carried into territory that was never treated. It is a mechanical event rather than an allergic one, and it can happen to an experienced injector.
Why is the damage not where I was injected?
Because the product travels with the blood flow and lodges at the far end of the vessel. A treated cheek can produce a pale patch on the nose, and an injection at the glabella can threaten the forehead. This is why an area that looks normal at the needle entry point can still be an emergency.
Does a blocked vessel always cause lasting damage?
No. How much tissue is affected depends on which vessel is involved, how much material entered it, and how quickly the problem is recognised. Some episodes resolve with no lasting change, and others lead to blistering, darkening and loss of skin. The outcome is not predictable at the outset, which is why the finding is treated as an emergency.
Risks & Limitations
- The site of the injection is not the site of the damage: filler that enters an artery is carried by the blood flow and lodges downstream.
- Only a filler of the enzyme-dissolvable class can be dissolved. Biostimulators, polycaprolactone and calcium-based fillers cannot.
- Dissolving the product removes the cause; it does not repair tissue that has already lost its blood supply.
- The glabella, nose, forehead, temple and tear trough share a blood supply with the eye, which is why they are treated with particular care.
- A change in vision after a facial injection is an emergency in which minutes matter, and recovery cannot be assumed.
- Where skin or vision has been lost, later treatment can improve an area but does not restore what was there before.
When to Seek Care
- Severe pain out of proportion to the injection, or pain that keeps worsening — seek emergency care now.
- Skin turning white, grey, mottled or dusky, a lacy or blotchy pattern, or skin that feels cold — seek emergency care now.
- Any change in vision, a drooping eyelid, or pain and swelling around the eye — seek emergency care now; minutes matter.
- Blistering, peeling or darkening skin over a treated area — seek emergency care now.
- A severe headache, or weakness or numbness on one side of the body — seek emergency care now and call emergency services.
- A reaction that is not settling but is not in this list — contact your treating team the same day.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — injectable filler safety guidance
- U.S. Food and Drug Administration (FDA) — dermal filler safety information
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.